Active surveillance an option for some low risk prostate cancer patients
Active surveillance of individuals with very-low-risk prostate cancer who are also on 5 α-reductase inhibitor therapy for benign prostatic hyperplasia seems to be a safe therapeutic option, say researchers.
No comments:
Post a Comment